Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

NCT06093126 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Insomnia
Dementia
Frontotemporal Dementia

Interventions

DRUG: Lemborexant 5 MG

Sponsor

Nova Scotia Health Authority